Skip to main content
SpringerLink
Log in

Psychopharmacology Principles

  • Chapter
  • First Online:
On-Call Geriatric Psychiatry

Abstract

This chapter reviews clinical pearls using the acronym AVOID to highlight some of the key principles of using psychotropic medications in the geriatric population. It also reviews the influence of aging on pharmacokinetics and pharmacodynamics. Finally, it explores common on-call conditions where medications are emphasized, while common on-call psychotropic medications are listed as an easy-to-reference table.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA. 2010;304(14):1592–601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in geriatric adults. J Am Geriatr Soc. 2015. doi:10.1111/jgs.13702.

    Google Scholar 

  3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.

    Article  PubMed  Google Scholar 

  4. Zimmerman K, Rudolph J, Salow M, Skarf LM. Delirium in palliative care patients: focus on pharmacotherapy. Am J Hosp Palliat Care. 2011;28(7):501–10.

    Article  PubMed  Google Scholar 

  5. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004;24(9):1177–85.

    Article  CAS  PubMed  Google Scholar 

  6. Lonergan E, Luxenberg J. Valproate preparations for agitation in dementia. Cochrane Database Syst Rev. 2009;(3):CD003945.

    Google Scholar 

  7. Kales HC, Gitlin LN. Lyketsos CG; Detroit Expert Panel on assessment and management of neuropsychiatric symptoms of dementia. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62(4):762–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Oesterheld JR. Transports. In: Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC, editors. Clinical manual of drug interaction: principles for medical practice. Washington, DC: American Psychiatric Publishing; 2009. p. 43–60.

    Google Scholar 

  9. Carlo AD, Alpert JE. Geriatric psychopharmacology: pharmacokinetic and pharmacodynamic considerations. Psychiatr Ann. 2015;45(7):336–41.

    Article  Google Scholar 

  10. Crone CC, Gabriel GM, DiMartini A. An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist. Psychosomatics. 2006;47(3):188–205.

    Article  PubMed  Google Scholar 

  11. McIntyre RS, Baghdady NT, Banik S, Swartz SA. The use of psychotropic drugs in patients with impaired renal function. Prim Psychiatry. 2008;15(1):73–88.

    Google Scholar 

  12. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352(21):2211–21.

    Article  CAS  PubMed  Google Scholar 

  13. Pollock B, Forsyth C, Bies R. The critical role of clinical pharmacology in geriatric psychopharmacology. Clin Pharmacol Ther. 2009;85(1):89–93. 14.

    Article  PubMed  Google Scholar 

  14. Stegemann S, Ecker F, Maio M, Kraahs P, Wohlfart R, Breitkreutz J, et al. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev. 2010;9(4):384–98.

    Article  PubMed  Google Scholar 

  15. Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, et al. Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study. JAMA Psychiatry. 2015;72(9):927–34.

    Article  PubMed  Google Scholar 

  16. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.

    Article  PubMed  Google Scholar 

  17. Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 2011;34(2):125–56.

    Article  CAS  PubMed  Google Scholar 

  18. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158(6):892–8.

    Article  CAS  PubMed  Google Scholar 

  19. Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer’s disease: case–control study. BMJ. 2014;349:g5205.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934–43.

    Article  CAS  PubMed  Google Scholar 

  21. Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry. 2007;164(10):1568–76. quiz 1623.

    Article  PubMed  Google Scholar 

  22. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ. 2007;176(5):627–32.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Health Canada. Risperidone product monograph. http://webprod5.hc-sc.gc.ca/dpd-bdpp/dispatch-repartition.do?lang=eng. Accessed 16 Oct 2015.

  24. Public Assessment Report of the Medicine Evaluation Board in the Netherlands. 2008. http://db.cbg-meb.nl/mri/par/nlh-1078-001-002-003-004-005-006.pdf. Accessed 9 Oct 2015.

  25. National Institute for Health and Clinical Excellence (NICE). 2010. Delirium: diagnosis, prevention and treatment. https://www.nice.org.uk/Guidance/CG103. Accessed 13 Oct 2015.

  26. Weintraub D, Hurtig HI. Presentation and management of psychosis in Parkinson’s disease and Dementia with Lewy bodies. Am J Psychiatry. 2007;164(10):1491–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database Syst Rev. 2011;(6):CD008537.

    Google Scholar 

  28. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191–204.

    Article  PubMed  Google Scholar 

  29. Baillargeon L, Landreville P, Verreault R, Beauchemin J-P, Grégoire J-P, Morin CM. Discontinuation of benzodiazepines among geriatric insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169(10):1015–20.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, University of California, Davis, 2230 Stockton Blvd., Sacramento, CA, 95817, USA

    Glen L. Xiong MD, CMD

  2. Mercy Medical Group, Geriatric Division, University of California, Davis, School of Medicine, 3000 Q Street, Sacramento, CA, 95816, USA

    Ashkan Javaheri MD, CMD

  3. Psychotropic Drug Safety Initiative, Office of Mental Health Operations, Department of Veterans Affairs, Northeast Program Evaluation Center, West Haven, CT, USA

    Ilse R. Wiechers MD, MPP, MHS

  4. Department of Psychiatry, Yale University School of Medicine, 950 Campbell Ave, NEPEC/182, West Haven, CT, 06516, USA

    Ilse R. Wiechers MD, MPP, MHS

Authors
  1. Glen L. Xiong MD, CMD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashkan Javaheri MD, CMD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilse R. Wiechers MD, MPP, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Glen L. Xiong MD, CMD .

Editor information

Editors and Affiliations

  1. Dept. of Psychiatry & Behavioural Neuros, McMaster University, Hamilton, Ontario, Canada

    Ana Hategan

  2. Dept. of Psychiatry/Langley Porter Psych, University of California San Francisco, San Francisco, New York, USA

    James A. Bourgeois

  3. Dept.of Internal Med.,Div of General Med, University of California Davis, Sacramento, California, USA

    Calvin H. Hirsch

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Xiong, G.L., Javaheri, A., Wiechers, I.R. (2016). Psychopharmacology Principles. In: Hategan, A., Bourgeois, J., Hirsch, C. (eds) On-Call Geriatric Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-30346-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30346-8_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30344-4

  • Online ISBN: 978-3-319-30346-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation